高齢者の脆弱性 高齢者の脆弱性
Andrew Clegg1, John Young, Steve Iliffe
1Academic Unit of Elderly Care and Rehabilitation, University of Leeds, Leeds, UK. a.p.clegg@leeds.ac.uk
Lancet (London, England)
|February 12, 2013
まとめ
弱さ,老化による脆弱性は,累積的な生理学的衰退の結果である. 早期発見方法は,高齢者のより良いケアと治療の選択に不可欠です.
科学分野:
- ゲロントロジーはゲロントロジーの学科です.
- 公衆衛生は公衆衛生である.
- クリニカル・メディシン 臨床医学
背景:
- 脆弱性は,人口高齢化における重要な課題であり,ストレス要因の後に脆弱性や貧弱なホメオスタシスが特徴です.
- それは生涯の累積的な生理学的衰退から生じ,貯蓄を枯渇させ,健康に悪影響を及ぼします.
- 現在の脆弱性モデルは流行病学的研究を可能にしますが,効率的な臨床検出方法は不足しています.
研究 の 目的:
- 通常の臨床実務において,より効率的な脆弱性検出方法の必要性を強調する.
- プライマリケアに焦点を当てた脆弱性評価ツールの重要性を強調する.
- 脆弱な高齢者のための目標指向のケアへの移行を提唱する.
主な方法:
- 概要は,里程碑的な研究における有効な脆弱性モデルの開発について論じています.
- このモデルは,これらのモデルを利用した疫学調査を参考にしています.
- 新しい効率的な検出方法の開発の必要性を強調しています.
主要な成果:
- 画期的な研究は,脆弱性の有効なモデルを確立しました.
- 疫学的な研究は,脆弱性と健康への悪影響との明確な関連性を示しています.
- 改善された臨床検出と重症度測定の必要性を特定しています.
結論:
- 脆弱性は,高齢者集団における重要な問題であり,健康状態と結果に影響を及ぼします.
- 初等医療における脆弱性検出の効率的な方法の開発は不可欠です.
- 脆弱性評価の改善により,適切な治療の選択と高齢者の目標指向のケアが容易になります.
関連する概念動画
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...


